Pancreatic cancer therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured Pancreas Neoplastic Stem Cells Pancreatic Ducts Pancreatic Stellate Cells Pancreatic Juice HCT116 Cells MCF-7 Cells Cell Line Breast HT29 Cells

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae Oncolytic Viruses

Diseases42

Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Neoplasms Adenocarcinoma Neoplasm Invasiveness Neoplasm Metastasis Breast Neoplasms Prostatic Neoplasms Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Disease Progression Stomach Neoplasms Neovascularization, Pathologic Carcinoma Pancreatitis Cell Transformation, Neoplastic Genetic Predisposition to Disease Pancreatitis, Chronic Liver Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Urinary Bladder Neoplasms Neoplasms, Experimental Disease Models, Animal Neoplasm Recurrence, Local Gastrointestinal Neoplasms Precancerous Conditions Carcinogenesis Peritoneal Neoplasms Endometrial Neoplasms Esophageal Neoplasms Rectal Neoplasms Head and Neck Neoplasms Carcinoma in Situ Melanoma Skin Neoplasms Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Mouth Neoplasms

Chemicals and Drugs69

Deoxycytidine Antineoplastic Agents Antimetabolites, Antineoplastic CA-19-9 Antigen Tumor Markers, Biological RNA, Small Interfering Neoplasm Proteins RNA, Messenger Cancer Vaccines Fluorouracil Tumor Suppressor Protein p53 Antibodies, Monoclonal Antigens, Neoplasm Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Antineoplastic Agents, Phytogenic Cisplatin DNA, Neoplasm Receptor, erbB-2 MicroRNAs Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt ras Proteins Tumor Suppressor Proteins Quinazolines Enzyme Inhibitors Smad4 Protein Anticarcinogenic Agents Antigens, Tumor-Associated, Carbohydrate Radiation-Sensitizing Agents Receptors, Estrogen Carcinoembryonic Antigen Vascular Endothelial Growth Factor A Mucin-4 Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins RNA, Neoplasm Paclitaxel Protein-Serine-Threonine Kinases Mucin-1 Antibodies, Monoclonal, Humanized Apoptosis Regulatory Proteins Transcription Factors Tamoxifen Nuclear Proteins Prostate-Specific Antigen Inhibitor of Apoptosis Proteins Antineoplastic Agents, Hormonal TNF-Related Apoptosis-Inducing Ligand TOR Serine-Threonine Kinases NF-kappa B Camptothecin Organoplatinum Compounds Curcumin Antibiotics, Antineoplastic Cell Cycle Proteins GPI-Linked Proteins Drug Carriers Histone Deacetylase Inhibitors Taxoids Cadherins Cyclooxygenase 2 Caspase 3 BRCA2 Protein Membrane Proteins DNA Primers Hydroxamic Acids Phosphatidylinositol 3-Kinases STAT3 Transcription Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Xenograft Model Antitumor Assays Early Detection of Cancer Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Molecular Targeted Therapy Antineoplastic Combined Chemotherapy Protocols Prognosis Blotting, Western Drug Delivery Systems Transplantation, Heterologous Survival Analysis Survival Rate Tumor Burden Combined Modality Therapy Drug Screening Assays, Antitumor Immunohistochemistry Clinical Trials as Topic Gene Expression Profiling Neoplasm Staging Risk Factors Pancreatectomy Genetic Therapy Retrospective Studies Prospective Studies Treatment Outcome Transfection Risk Models, Biological Follow-Up Studies Chemotherapy, Adjuvant Gene Knockdown Techniques Risk Assessment Oligonucleotide Array Sequence Analysis Palliative Care Disease-Free Survival Kaplan-Meier Estimate Odds Ratio Registries Flow Cytometry Immunotherapy Sensitivity and Specificity Radiotherapy Neoplasms, Experimental Disease Models, Animal Tissue Array Analysis Pancreaticoduodenectomy Polymerase Chain Reaction Multivariate Analysis SEER Program Immunoenzyme Techniques Endosonography Incidence Questionnaires Reproducibility of Results Radiotherapy, Adjuvant Predictive Value of Tests Inhibitory Concentration 50 Case-Control Studies Cohort Studies Real-Time Polymerase Chain Reaction Drug Administration Schedule Logistic Models Tumor Stem Cell Assay Oncolytic Virotherapy Drug Design Confidence Intervals Individualized Medicine Drug Carriers Hyperthermia, Induced DNA Mutational Analysis Drug Evaluation, Preclinical Mammary Neoplasms, Experimental

Psychiatry and Psychology1

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Drug Resistance, Neoplasm Cell Survival Signal Transduction Cell Growth Processes Cell Movement Mutation RNA Interference Cell Cycle Genetic Predisposition to Disease Down-Regulation Cell Division Dose-Response Relationship, Drug Drug Synergism Up-Regulation Transfection Genes, ras Risk Gene Silencing Odds Ratio Epithelial-Mesenchymal Transition DNA Methylation Phosphorylation Sensitivity and Specificity Genes, Tumor Suppressor Promoter Regions, Genetic Tumor Microenvironment Gene Expression Genes, Neoplasm Time Factors Genotype Genes, p53 DNA Damage Germ-Line Mutation Radiation Tolerance Base Sequence Genetic Vectors Genes, BRCA1 Inhibitory Concentration 50 Cell Death Phenotype Diet Enzyme Activation Cell Hypoxia Genes, BRCA2 Polymorphism, Genetic Autophagy Oncogenes Protein Binding

Disciplines and Occupations5

Immunohistochemistry Medical Oncology Nanomedicine Drug Design Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture2

Nanoparticles Nanomedicine

Humanities1

Quality of Life

Information Science7

Survival Rate Registries SEER Program Incidence Questionnaires Base Sequence Molecular Sequence Data

Named Groups1

Health Care28

Survival Analysis Survival Rate Clinical Trials as Topic Risk Factors Retrospective Studies Prospective Studies Treatment Outcome Risk Follow-Up Studies Risk Assessment Palliative Care Disease-Free Survival Kaplan-Meier Estimate Odds Ratio Registries National Cancer Institute (U.S.)Sensitivity and Specificity Multivariate Analysis Age Factors SEER Program Incidence Questionnaires Reproducibility of Results Predictive Value of Tests Case-Control Studies Cohort Studies Logistic Models Confidence Intervals

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Pancreatic Neoplasms Xenograft Model Antitumor Assays Cell Line, Tumor Mice, Nude Carcinoma, Pancreatic Ductal Neoplasms Deoxycytidine Antineoplastic Agents Adenocarcinoma Gene Expression Regulation, Neoplastic Cell Proliferation Early Detection of Cancer Neoplasm Invasiveness Antimetabolites, Antineoplastic Apoptosis Neoplasm Metastasis Drug Resistance, Neoplasm CA-19-9 Antigen Breast Neoplasms Neoplasm Transplantation Tumor Markers, Biological Prostatic Neoplasms Lung Neoplasms RNA, Small Interfering Tumor Cells, Cultured Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins Cell Survival Signal Transduction Colonic Neoplasms Ovarian Neoplasms Molecular Targeted Therapy Antineoplastic Combined Chemotherapy Protocols Pancreas Prognosis Blotting, Western Disease Progression Drug Delivery Systems Transplantation, Heterologous Survival Analysis RNA, Messenger Stomach Neoplasms Survival Rate Tumor Burden Combined Modality Therapy Neovascularization, Pathologic Cancer Vaccines Cell Growth Processes Carcinoma Pancreatitis Cell Transformation, Neoplastic Cell Movement Fluorouracil Drug Screening Assays, Antitumor Immunohistochemistry Tumor Suppressor Protein p53 Mutation RNA Interference Clinical Trials as Topic Neoplastic Stem Cells Mice, SCID Gene Expression Profiling Medical Oncology Cell Cycle Genetic Predisposition to Disease Pancreatitis, Chronic Neoplasm Staging Down-Regulation Risk Factors Pancreatectomy Genetic Therapy Cell Division Antibodies, Monoclonal Antigens, Neoplasm Retrospective Studies Prospective Studies Dose-Response Relationship, Drug Protein Kinase Inhibitors Drug Synergism Treatment Outcome Receptor, Epidermal Growth Factor Up-Regulation Transfection Pancreatic Ducts Genes, ras Risk Gene Silencing Liver Neoplasms Models, Biological Antineoplastic Agents, Phytogenic Colorectal Neoplasms Follow-Up Studies Cisplatin United States DNA, Neoplasm Chemotherapy, Adjuvant Gene Knockdown Techniques Receptor, erbB-2 MicroRNAs Mice, Inbred BALB C

No FAQ available that match "pancreatic cancer therapy"